Specialises in breast cancer, GU cancer, prostate cancer, SBRT, DIBH, hypofractionation, survivorship, education
Tracy obtained her undergraduate medical degree in British Columbia, Canada in 2002 after completing a PhD in genetics in 1998. She moved her family across the country to Ontario Canada for her specialty training in Radiation Oncology and after obtaining her fellowship in 2007 began her career as a Radiation Oncologist at the London Regional Cancer Program in London Canada where she worked for the last 15 years.
Tracy has been actively involved in the education of medical students and residents and was the Radiation Oncology Program Director for 10 years during which she was heavily involved in the national transition to competency based medical education through the Royal College.
As a 16 year breast cancer survivor she has a commitment to building survivorship programs and improving patients lives through teamwork
Areas of interest: breast, GU and pediatric malignancies; survivorship
Other interests: 11 year member of Rowbust, London breast cancer survivor dragonboat racing team
Since moving to Australia I enjoy spending time with my daughter, who is a primary school teacher in Melbourne, traveling and spending time on the water
Awards Received
- Awards received 2011 – Excellence in Academics Award, The University of Western Ontario, London, Ontario, Canada
Research interests
- I actively enrol patients in clinical trials and have an interest in circulating tumor cell translational research in breast and prostate cancer as well as PSMA-PET imaging for prostate patients
Publications and affiliations
- Mendez LC, Arifin AJ, Bauman GS, Velker VM, Ahmad B, Lock M, Venkatesan VM, Sexton TL, Rodrigues GB, Chen J, Schaly B, Warner A, D’Souza DP. Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial. BMC Cancer, 2020 Oct 9; 20 (1): 978, Coauthor, DOI: 10.1186/s12885-020-07490-0.
- Borrie AE, Rose FA, Choi YH, Perera FE, Read N, Sexton T, Lock M, Vandenberg TA, Hahn K, Younus J, Logan D, Potvin K, Yaremko B, Yu E, Lenehan J, Welch S, Teft WA, Kim RB. Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast Cancer Res Treat, 2020 Jul 6, Coauthor, DOI: 10.1007/s10549-020-05777-1.
- Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. Int J Radiat Oncol Biol Phys, 2020 Mar 1; 106 (3): 546-555, Coauthor, DOI: 10.1016/j.ijrobp.2019.11.001.
- Guidolin K, Yaremko B, Lynn K, Gaede S, Kornecki A, Muscedere G, BenNachum I, Shmuilovich O, Mouawad M, Yu E, Sexton T, PhD MD, Gelman N, Moiseenko V, Brackstone M, Lock M. Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy. Curr Oncol, 2019 Jun 1; 26 (3): e334-e340, Coauthor, DOI: 10.3747/co.26.4479.
- McPherson VA, Rodrigues G, Bauman G, Winquist E, Chin J, Izawa J, Potvin K, Ernst S, Venkatesan V, Sexton T, Ahmad B, Power N. Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer. Can Urol Assoc J, 2017 Jan 1; 11 (1-2): E64-E65, Coauthor, DOI: 10.5489/cuaj.4476.
Professional memberships
- Radiation Oncology Residency Program Director Western university, Canada 2008-2018
- National Program Director Committee for Competency-based medical education for Radiation Oncology, RCPSC, Canada 2016-2018
- Southwest regional lead breast cancer survivorship, Ontario, Canada 2012-2021
- Chair Medical Advisory Panel, International Breast Cancer Paddling Commission 2021-present
- Royal College of Physicians and Surgeons of Canada (RCPSC)